Oxford Impedance Diagnostics - operationalising a disruptive Point of Care platform

Oxford Impedance Diagnostics - 运营颠覆性的护理点平台

• 批准号: 133352
• 金额: $ 13.27万
• 依托单位: OSLER DIAGNOSTICS LIMITED
• 依托单位国家: 英国
• 项目类别: Feasibility Studies
• 财政年份: 2018
• 资助国家: 英国
• 起止时间: 2018 至 无数据
• 项目状态: 已结题
• 来源: https://gtr.ukri.org/projects?ref=133352
• 关键词: Oxford; Impedance; Diagnostics; operationalising; disruptive

We are developing a point of care (POC) diagnostic device that can perform most of the tests a conventional laboratory does, but in a hand held device that can sit on a GPs desk. Not only small, the device will also be cheap, accurate, and comprehensive (as it can test for a huge range of conditions). With such a device, doctors could diagnose patients live, rather than sending off a sample to a lab, dramatically reducing the cost of diagnostic testing across the NHS, and significantly improving patient outcomes and health through earlier diagnosis. Our company has been developing this device based off of research from the University of Oxford. We have already proven the principle of this device in our research laboratory, including against key markers like insulin, Zika, and cardiac markers CRP and Troponin. We are now operationalising the technology, with the ultimate goal of producing a commercial product.

我们正在开发一种床旁（POC）诊断设备，可以执行传统实验室的大部分测试，但在一个手持设备，可以坐在一个全球定位系统的办公桌上。该设备不仅体积小，而且价格便宜，准确和全面（因为它可以测试各种条件）。有了这样的设备，医生可以现场诊断患者，而不是将样本送到实验室，大大降低了整个NHS的诊断测试成本，并通过早期诊断显着改善患者的预后和健康。我们公司根据牛津大学的研究开发了这种设备。我们已经在我们的研究实验室中证明了该设备的原理，包括针对胰岛素，寨卡病毒和心脏标志物CRP和肌钙蛋白等关键标志物。我们现在正在实施这项技术，最终目标是生产商业产品。